Susquehanna International Group
CLOV icon

Susquehanna International Group’s Clover Health Investments CLOV Stock Holding History

Susquehanna International Group’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.58M Sell
898,557
-1,426,696
-61% -$3.09M ﹤0.01% 6728
2025
Q4 		$5.46M Sell
2,325,253
-376,643
-14% -$1.03M ﹤0.01% 3879
2025
Q3 		$8.27M Sell
2,701,896
-289,857
-10% -$828K ﹤0.01% 3288
2025
Q2 		$8.35M Buy
2,991,753
+829,541
+38% +$2.73M ﹤0.01% 3106
2025
Q1 		$7.76M Sell
2,162,212
-577,466
-21% -$2.32M ﹤0.01% 2879
2024
Q4 		$8.63M Buy
2,739,678
+860,480
+46% +$3.08M ﹤0.01% 2839
2024
Q3 		$5.3M Sell
1,879,198
-529,780
-22% -$1.21M ﹤0.01% 3503
2024
Q2 		$2.96M Sell
2,408,978
-1,212,047
-33% -$1.09M ﹤0.01% 4331
2024
Q1 		$2.88M Sell
3,621,025
-53,449
-1% -$48.6K ﹤0.01% 4604
2023
Q4 		$3.5M Buy
3,674,474
+2,200,692
+149% +$2.16M ﹤0.01% 4321
2023
Q3 		$1.59M Sell
1,473,782
-927,891
-39% -$1.1M ﹤0.01% 5605
2023
Q2 		$2.15M Buy
2,401,673
+1,021,849
+74% +$906K ﹤0.01% 5001
2023
Q1 		$1.17M Sell
1,379,824
-487,848
-26% -$534K ﹤0.01% 6415
2022
Q4 		$1.74M Sell
1,867,672
-622,477
-25% -$831K ﹤0.01% 4982
2022
Q3 		$4.23M Buy
2,490,149
+5,561
+0.2% +$14.6K ﹤0.01% 3423
2022
Q2 		$5.32M Sell
2,484,588
-4,830,074
-66% -$12.8M ﹤0.01% 3081
2022
Q1 		$26M Buy
7,314,662
+2,262,376
+45% +$6.56M ﹤0.01% 1463
2021
Q4 		$18.8M Sell
5,052,286
-1,045,759
-17% -$6.41M ﹤0.01% 1920
2021
Q3 		$45.1M Buy
6,098,045
+3,165,985
+108% +$27.1M 0.01% 1235
2021
Q2 		$39.1M Buy
2,932,060
+761,555
+35% +$7.48M 0.01% 1387
2021
Q1 		$16.4M Buy
2,170,505
+22,882
+1% +$258K ﹤0.01% 2125
2020
Q4 		$36M Buy
+2,147,623
New +$23.9M 0.01% 1229

Other funds holding CLOV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group's CLOV Position: Q1 2026 in Review

Susquehanna International Group reduced its Clover Health Investments (CLOV) stake by 61% in Q1 2026, selling an estimated $3.09M and leaving 898,557 shares worth $1.58M. The position accounts for ﹤0.01% of the portfolio, ranked #6728.

Susquehanna International Group first reported a position in CLOV in Q4 2020 and has held it in 22 quarters since. The position peaked at $45.1M in Q3 2021. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Susquehanna International Group held 898,557 shares of Clover Health Investments worth $1.58M as of Q1 2026.
  • Susquehanna International Group sold 1,426,696 Clover Health Investments shares in Q1 2026, an estimated $3.09M.
  • Clover Health Investments made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6728 holding.
  • Susquehanna International Group first reported a position in Clover Health Investments in Q4 2020 and has held it in 22 quarters since.
  • Susquehanna International Group's Clover Health Investments position peaked at $45.1M in Q3 2021.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.